Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ming Chen

15PUBLICATIONS

18CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markersRadiation therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Nov 07, 2024

TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial.

Baiqiang Dong, Long Chen, Qingsong Pang

|Jul 11, 2024

Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trials.

Dijian Shen, Runzhe Chen, Qing Wu

|Mar 06, 2024

Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.

Shuzhen Lai, Peijing Li, Xiaohui Liu

|Oct 06, 2023

PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer.

Huan Deng, Yamei Chen, Li Wang

|Feb 22, 2022

A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma.

Yujin Xu, Baiqiang Dong, Weiguo Zhu

|Jan 08, 2022

Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review.

Yamei Chen, Ying Jin, Xiao Hu

Pageof 3

Frequent Collaborators

3 joint publications

Yuanyuan Chen

2 joint publications

Zhengbo Song

2 joint publications

Baiqiang Dong

1 joint publications

Li Qinglin

1 joint publications

Zhipeng Zhou

1 joint publications

Pansong Li

1 joint publications

Rongrong Zhou

1 joint publications

Zhongxing Liao

1 joint publications

Ming Zeng

1 joint publications

Zhigang Liu

Frequent Collaborators

3 joint publications

Yuanyuan Chen

2 joint publications

Zhengbo Song

2 joint publications

Baiqiang Dong

1 joint publications

Li Qinglin

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on : Apr 22, 2019

See more related videos